Gaurav Mehta
LinkedIn Copy
Hey Gaurav — similar path (IB → PE). been thinking a lot about proprietary origination in healthcare lately. would be good to connect.
Hey Gaurav, looks like we share a similar IB → PE path, though I was in London at CS & Greenhill not on the Citi / Barclays side like you. origination was always the same story for me — clear thesis, decent relationships, but no proprietary system of record. the people, tools and ideas were never really connected. every deal virtually sourced from scratch, nothing compounding over time. curious if that's still how most funds operate or if I'm behind the times? — Russ
Hey Gaurav, looks like we came up through a similar IB → PE path, though I was in London doing growth equity deals at Treis not in NYC building a healthcare-focused firm like you've done with Mehshah. the pattern I keep seeing with most funds is weirdly consistent — strong thesis, solid network, but no proprietary system of record. the people, tools and ideas are never really connected. every deal virtually sourced from scratch, nothing compounds on itself. curious if that resonates or if you've built something different at Mehshah? — Russ
hey Gaurav — no worries if the timing's off. most funds I talk to have tried some version of building origination in-house — analyst pulling from Pitchbook or Grata, maybe using ChatGPT to help qualify, dumping it into a spreadsheet. each piece kind of works, but there's no system of record tying it together. the people, tools and ideas are all disconnected, so there's tonnes of wasted energy and everything ends up out of sync. been helping a few funds like Mentmore work through that. curious if you've run into the same thing at Mehshah? — Russ
totally get it if origination infrastructure isn't top of mind right now — most funds have 10 things ahead of it on the priority list. the funds I've seen crack it early just tend to compound deal flow in a way that's hard to replicate later. if it ever moves up the list, I'm easy to find. — Russ
Email Copy
Gaurav — We've been building custom deal sourcing systems for PE and growth equity funds, and a few of our clients run a similar playbook to what Mehshah does — targeting specific verticals, scoring companies against a defined thesis, and booking meetings with founders while the team focuses on portfolio work. also, incidentally, we share a fairly similar path — I did investment banking (Credit Suisse, then Greenhill in London) before moving to the direct investing side at a growth equity fund. so figured it made sense to reach out. One client that might be relevant: Backer Group in the UK sources founder-led service businesses, scores them on acquisition fit and owner readiness, then runs personalized outreach across email, LinkedIn, and letters — all plugged into their CRM with live updates. They're a small team, so the system handles origination in the background while they focus on closing and managing the portfolio. We've built similar setups for software-focused funds too (Axiom Equity, Noble Rock, Wingman) but the architecture flexes to whatever the thesis is — healthcare staffing, direct primary care, whatever the vertical. Given we've already built out this kind of infrastructure for funds with a similar profile to yours, I wondered if you wanted to take a look under the hood? LPs tend to like it when funds can show them a proprietary sourcing strategy too, which is a nice side benefit. fairly free this week and next, just let me know if you're curious. very best, Russell searchloop.ai linkedin.com/in/russellt23
Prospect Research
## PROSPECT INFORMATION: Name: Gaurav Mehta Title: Founder and Managing Partner Fund: Mehshah Capital Background: PROSPECT SUMMARY: GAURAV MEHTA CURRENT ROLE & FOCUS: Gaurav is the Founder and Managing Partner at Mehshah Capital, a New York-based private equity firm he launched in 2018. He specializes in healthcare and business services, focusing on both majority and minority stakes. His current portfolio includes Frontier Direct Care, GoTu (formerly TempMee), and Persimmon. He is deeply involved in "care-centric" health benefits and technology-enabled staffing marketplaces. BACKGROUND: With over 18 years of experience, Gaurav has a heavy concentration in Healthcare Investment Banking and Private Equity. Prior to Mehshah Capital, he was a Director at Pinta Capital Partners and held senior roles at Citi, Canaccord Genuity, and Barclays. Early in his career, he worked in corporate development at US Oncology (acquired by McKesson) and as a Hedge Fund Associate at Bridgewater Associates. He holds a B.S. in Chemical Engineering from UC Berkeley. KEY SKILLS: Private Equity, Healthcare M&A, Financial Modeling, Due Diligence, Corporate Development, Investment Banking, and Portfolio Management. RECENT POSTS & QUOTES: - November 18, 2025: Announced a partial exit from GoTu and a $45M growth investment. Quote: "We made an investment into GoTu, a technology-enabled dental talent marketplace recognizing the significant clinician shortage across the dental industry (which is often overshadowed by the ongoing doctor and nurse shortage)." - May 9, 2025: Shared a Forbes article featuring his portfolio company. Quote: "Great article about direct primary care. Thank you Web Golinkin for featuring Frontier Direct Care!" - January 8, 2025: Announced a major Series B funding round. Quote: "I'm proud to announce the initial closing of Mehshah Capital's $20 million Series B investment in Frontier Direct Care! ... This approach is driving real cost savings while improving access to high-quality care." - November 28, 2023: Commented on cybersecurity in the sector. Quote: "IT security is a critical need, particularly for healthcare which has been a slower adopter of technology than other industries... The latest ransomware attack at Ardent is just another example of the increasing challenges." - September 13, 2023: Discussed the value-based care movement. Quote: "The underlying assumption in all of these acquisitions is that the primary care physician is the most empowered point of contact for managing a patient's health." - August 28, 2023: Analyzed the contraction of the contract labor market. Quote: "The necessity for technology has transitioned from being a mere 'nice-to-have' to an essential 'must-have.' ... technology-enabled agencies are gaining traction and taking market share." Fund details: - Description: Mehshah Capital is a private equity firm focused on investing in the healthcare industry. The partners have over 30 years of combined healthcare investing and operational experience. We employ a thematic investment approach, looking for opportunities which are best positioned for transformational change. We harness the power of our extensive experience, deep industry relationships, and cutting-edge technology to drive accelerated growth for companies within our portfolio. Innovation, passion, and collaboration are the backbone of our model to achieve success. - Website: https://mehshah.com - Location: New York, New York, United States - Lead qualification: Research: - Query: =Mehshah Capital Gaurav Mehta recent investments fund thesis - Answer: Gaurav Mehta recently led Mehshah Capital's $20 million Series B investment in Frontier Direct Care, focusing on transforming employer-sponsored healthcare. Mehta is the founder and managing partner of Mehshah Capital, a private equity firm.